Prevention of sarcopenia among young-old adults with possible sarcopenia in the community Musculoskeletal Diseases
Conditions
Interventions
Current interventions:
A single-arm prospective pre-post study will be conducted to evaluate the feasibility, acceptability, and preliminary impact of the social-media-based health education plus exe
Sponsors
University of Manchester
China Scholarship Council
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. 60 - 69 years old 2. Chinese residents living in the community 3. Willingness to use TikTok 4. Individuals with possible sarcopenia, as defined by low Grip Strength [M:<28 kg, F:<18kg] in accordance with the 2019 Asian working group consensus on diagnosis criteria for sarcopenia 5. Informed consent for screening and research
Exclusion criteria
Exclusion criteria: 1. Unable to communicate or independently complete learning and exercise using TikTok 2. Serious or unstable medical illness, such as severe cardiovascular or respiratory conditions, mental disorders, dementia, etc. 3. Currently undertaking moderate-intensity exercise (= 150mins/week) 4. Contraindications for the use of Bioelectrical Impedance Analysis (BIA), such as people with implanted cardiac pacemakers, or other electronic devices or metal grafts, or with significant pitting oedema, or with limb dysfunction or body paralysis, or while taking medications that affect body composition, such as diuretics or glucocorticoids
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility and acceptability measured using a Research record sheet (Self-developed) throughout the study | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 01/02/2024: 1. Handgrip strength measured using a Digital hand-held dynamometer at T0, 4, 7, 10, and 13 2. Anthropometric measurements (e.g. weight, height) measured using a Stadiometer + Scale + Plastic tape at T0, 10 and 13 3. Body composition (e.g. muscle mass, body fat) measured using a Bioelectrical impedance analyzer device at T0, 4, 7, 10, and 13 4. Physical performance measured using the 4-Meter Walk Test and the Five Times Sit to Stand Test both at T0, 10 and 13 5. Nutrition state measured using the Mini-Nutritional Assessment Short Form at T0, 10 and 13 6. Perceived knowledge measured using 21 true or false quizzes related to sarcopenia (Self-developed) at T0, 1, 4, 10 and 13 7. Personal motivation measured using the Self-efficacy for Managing Chronic Disease 6-item Scale at T0, 10 and 13 8. Behavioural skills measured using the Self-management Behaviour for Chronic Disease Scale at T0, 10 and 13 9. Behaviour change monitoring measured using an Exercise adherence sheet (Self-developed) throughout the study, Records of viewing and sharing sarcopenia-related information (Self-developed) throughout the study, Willingness to formulate habits of regular exercise (Self-developed) at T0, 10 and 13 and Records of exposure percentage of exercise and sarcopenia related videos (Self-developed) at T0, 4, 7, 10, and 13 T0 = baseline; T1= 1-week post-intervention; T4= 3-week post-intervention; T7 = 6-week post-intervention; T10 = 3-week follow-up; T13 = 6-week follow-up. Previous secondary outcome measures: 1. Handgrip strength measured using a Digital hand-held dynamometer at T0, 4, 7, 10, 13, 16 and 19 2. Anthropometric measurements (e.g. weight, height) measured using a Stadiometer + Scale + Plastic tape at T0, 10 and 19 3. Body composition (e.g. muscle mass, body fat) measured using a Bioelectrical impedance analyzer device at T0, 4, 7, 10, 13, 16 and 19 4. Physical performance measured using the 4-Meter Walk Test and the | — |
Countries
China
Outcome results
None listed